Archives
-
CFDA SE Cell Tracer Kit: Workflow Guide
2026-08-28
The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for cell lineage tracing, cell proliferation studies, and selected tracking workflows. It is intended for persistent covalent marking rather than reversible labeling or short-term real-time physiological monitoring.
-
Circ-ECH1–miR-708-5p Axis in BPD
2026-08-27
A Journal of Cellular Biochemistry study identifies circ-ECH1 as a potentially protective regulator in hyperoxia-associated bronchopulmonary dysplasia. Its experiments connect reduced circ-ECH1 with miR-708-5p activity and Ntrk2 expression, providing a mechanistic framework for interpreting epithelial injury, oxidative stress, apoptosis, and fibrosis.
-
Temafloxacin Activity Against Gram-Positive Bacteria
2026-08-27
The 1991 reference study combined broth microdilution testing of bloodstream isolates with a literature review to define temafloxacin activity against clinically important Gram-positive cocci. Its findings showed strong activity against oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus, while also identifying environmental factors that can modestly influence susceptibility measurements.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-26
Build reproducible immunofluorescence and flow cytometry workflows for mouse primary antibodies, with practical guidance for porcine oocyte studies of O-GlcNAcylation, mitochondrial function, and cytoskeletal remodeling. The article combines assay design, quantified starting conditions, controls, and troubleshooting for reliable mouse IgG detection.
-
(-)-Blebbistatin for Reliable Cell Assays
2026-08-26
Learn how (-)-Blebbistatin (SKU B1387) can separate non-muscle myosin II-dependent mechanics from true cytotoxicity, improving interpretation of viability, proliferation, adhesion, and cardiac cell experiments. This scenario-based guide covers mechanism, controls, preparation, optimization, and practical product-selection criteria.
-
IGF2BP2, Glycolysis, and Ovarian Cancer Progression
2026-08-25
The reference study integrates single-cell and bulk transcriptomic data with genetic, metabolic, flow-cytometric, and RIP-seq experiments to identify IGF2BP2 as a cell type–specific m6A reader associated with ovarian cancer progression. Its findings connect IGF2BP2 to post-transcriptional control of proliferation, survival, and glycolysis, while pharmacological inhibition supports the feasibility of targeting this pathway.
-
SD 169: Applied p38 MAPK Research Workflows
2026-08-25
SD 169 enables controlled inhibition of p38α and p38β for inflammation, type 1 diabetes research, apoptosis assays, and axonal regeneration studies. This workflow-focused guide connects compound handling with time-resolved pathway measurements, phosphatase-aware experiments, and practical troubleshooting.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-08-24
FerroOrange is a Fe²⁺ fluorescent probe for resolving intracellular iron changes in living cells by microscopy, flow cytometry, or plate-reader analysis. This guide translates the Fra2/LCN2 macrophage-ferroptosis findings into practical assay design, controls, and troubleshooting strategies.
-
Measuring Apoptosis in ALK+ ALCL
2026-08-24
GANT61-induced apoptosis in ALK-positive anaplastic large cell lymphoma illustrates why pathway studies need direct, live-cell measurement of phosphatidylserine exposure. This thought-leadership guide connects the Hh–PIK3IP1–Akt mechanism with Annexin V-PE workflow design, assay selection, translational interpretation, and practical validation strategy.
-
NETs and IL-36R in Psoriasis: Study Insights
2026-08-23
The reference study identifies a feed-forward inflammatory circuit in which TLR3-driven NET formation is intensified by ATP-P2X7R signaling and linked to IL-1β decoration of NETs. Its cellular and mouse-model evidence positions IL-36R as an amplifier of NET-associated inflammation, while also highlighting timing and model-specific factors that matter for therapeutic interpretation.
-
From Broad-Spectrum Vaccines to Better IgG Readouts
2026-08-22
Broad-spectrum vaccine research depends on more than neutralization data: it also requires reproducible measurement of antibody binding, localization, and cellular distribution. This thought-leadership article examines how secondary-antibody design connects mechanistic immunology with translational assay strategy. It explains where the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody fits across immunofluorescence, Western blotting, flow cytometry, immunohistochemistry, and ELISA, while defining its limitations for animal-derived samples and neutralization claims.
-
GSDMC Links PDAC Stemness to Immune Evasion
2026-08-22
This Advanced Science study identifies Gasdermin C (GSDMC) as a noncanonical nuclear regulator of pancreatic ductal adenocarcinoma progression, rather than only a pyroptosis-associated pore-forming protein. Its findings connect GSDMC cleavage, cancer stemness, metastasis, and CXCL9-dependent immune evasion, while suggesting that GSDMC-directed intervention may improve responses to KRASG12D inhibition and PD-1 blockade.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Three Readouts
2026-08-21
EZ Cap Cy5 Firefly Luciferase mRNA unifies fluorescent cargo tracking with functional luciferase expression. This article presents a three-readout framework for separating uptake, intracellular release, and translation during mRNA delivery and transfection studies.
-
ATM–Fenofibrate Synergy in High-Grade Serous Ovarian Cancer
2026-08-20
The reference study identifies a metabolic vulnerability created by ATM inhibition in high-grade serous ovarian cancer (HGSOC) cells. By integrating tumor datasets, drug-dependency analysis, and cell-based validation, it shows that combining ATM inhibition with the PPARα agonist fenofibrate can induce synergistic growth suppression and cellular senescence, offering a rationale for treatment strategies beyond homologous recombination deficiency.
-
β-Elemene in Adipogenesis Research: Practical Workflows
2026-08-20
Translate β-Elemene activity into a reproducible 3T3-L1 adipogenesis and insulin-resistance workflow with orthogonal lipid, viability, glucose, and pathway readouts. The same compound also supports carefully bounded investigations of neuroprotection, inflammation, and analytical method performance.